Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $498 Billion
  • Q1 2024

Artia Global Partners LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $498 Billion distributed in 49 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Novo Nordisk A S with a value of $88.8B, Eli Lilly & CO with a value of $72B, Merck & Co., Inc. with a value of $50B, Viking Therapeutics, Inc. with a value of $35.6B, and Abb Vie Inc. with a value of $16.5B.

Examining the 13F form we can see an increase of $154B in the current position value, from $344B to 498B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $498 Billion
Healthcare: $395 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$322B
$88.8 Billion 17.85% of portfolio
691,743
Q1 2024 Reduced 4.13%
$860B
$72 Billion 14.48% of portfolio
92,593
Q4 2023 Added 253.5%
$314B
$50 Billion 10.06% of portfolio
379,200
Q1 2024 Added 15.19%
$4.07B
$35.6 Billion 7.15% of portfolio
433,580
Q1 2024 Added 13.04%
$303B
$16.5 Billion 3.32% of portfolio
90,821
Q4 2022 New
$6.47B
$14.5 Billion 2.92% of portfolio
210,096
Q1 2024 Added 405.04%
$23.8B
$13.5 Billion 2.71% of portfolio
34,238
Q4 2023 Reduced 30.46%
$242B
$12.9 Billion 2.6% of portfolio
190,752
Q2 2023 Added 86.45%
$120B
$12.1 Billion 2.43% of portfolio
28,900
Q1 2024 New
$3.45B
$7.01 Billion 1.41% of portfolio
87,848
Q2 2023 New
$526M
$6.59 Billion 1.33% of portfolio
724,685
Q1 2024 Added 64.7%
$5.1B
$6.28 Billion 1.26% of portfolio
89,525
Q1 2024 Added 178.78%
$13.2B
$6.21 Billion 1.25% of portfolio
45,000
Q4 2022 New
Disc Medicine Inc
-
$5.42 Billion 1.09% of portfolio
-
Q1 2024 New
$4.48B
$5.21 Billion 1.05% of portfolio
76,255
Q1 2024 Added 97.78%
Apogee Therapeutics Inc
-
$4.09 Billion 0.82% of portfolio
-
Q1 2024 Added 493.3%
$1.7B
$3.6 Billion 0.72% of portfolio
124,440
Q1 2024 Added 10.77%
$1.83B
$3.39 Billion 0.68% of portfolio
119,488
Q1 2024 New
$9.08B
$3.21 Billion 0.64% of portfolio
118,236
Q1 2024 Added 57.78%
$2.35B
$2.65 Billion 0.53% of portfolio
53,930
Q1 2024 New
$7.61B
$2.4 Billion 0.48% of portfolio
15,894
Q1 2024 New
$1.69B
$2.3 Billion 0.46% of portfolio
52,492
Q1 2024 New
$2.71B
$2.26 Billion 0.45% of portfolio
50,171
Q1 2024 New
$881M
$2.1 Billion 0.42% of portfolio
130,790
Q4 2023 New
$0
$2.05 Billion 0.41% of portfolio
51,714
Q1 2024 New
$10.5B
$1.87 Billion 0.38% of portfolio
6,905
Q1 2023 New
$1.75B
$1.81 Billion 0.36% of portfolio
47,949
Q1 2024 New
$2.43B
$1.72 Billion 0.35% of portfolio
40,000
Q1 2024 New
Soleno Therapeutics Inc
-
$1.75 Billion 0.35% of portfolio
-
Q1 2024 New
$1.42B
$1.65 Billion 0.33% of portfolio
40,000
Q1 2024 New
$523M
$1.49 Billion 0.3% of portfolio
100,000
Q2 2023 New
$450M
$1.39 Billion 0.28% of portfolio
421,359
Q1 2024 New
-
$1.28 Billion 0.26% of portfolio
-
Q1 2024 New
$90.5M
$1.23 Billion 0.25% of portfolio
137,308
Q1 2024 Added 599.2%
$682M
$1.13 Billion 0.23% of portfolio
52,476
Q1 2024 New
$296M
$1.06 Billion 0.21% of portfolio
51,500
Q1 2024 Added 3.0%
$978M
$1.05 Billion 0.21% of portfolio
24,298
Q1 2024 New
$233M
$1.06 Billion 0.21% of portfolio
147,485
Q1 2024 New
$261M
$942 Million 0.19% of portfolio
64,007
Q1 2024 New
$1.38B
$842 Million 0.17% of portfolio
39,478
Q1 2024 New
$3.41B
$691 Million 0.14% of portfolio
21,397
Q4 2023 New
$132M
$530 Million 0.11% of portfolio
35,452
Q1 2024 Added 39.29%
$314M
$442 Million 0.09% of portfolio
58,190
Q1 2024 New
$4.79B
$416 Million 0.08% of portfolio
1,557
Q1 2024 New
$250M
$274 Million 0.06% of portfolio
86,002
Q1 2024 New
$45.3M
$245 Million 0.05% of portfolio
95,170
Q2 2023 New

Summary

  • Portfolio
  • No. of Stocks 49
  • Current Value $498 Billion
  • Prior Value $344 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 23 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email